Pediatrics – Hematology/Oncology
ASCO Guideline | Management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients
24 Jan, 2023 | 14:28h | UTC
NCCN Guideline | Pediatric central nervous system cancers
12 Jan, 2023 | 13:11h | UTCEditorial: ASCO Living Guidelines: The Next Frontier
Review | Palliative care for adolescents and young adults with advanced illness.
12 Dec, 2022 | 12:33h | UTC
Joint consensus statement on the vaccination of adult and pediatric hematopoietic stem cell transplant recipients.
30 Nov, 2022 | 13:39h | UTC
Guideline | Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients.
8 Nov, 2022 | 12:21h | UTC
RCT | Brentuximab Vedotin with chemotherapy in pediatric high-risk Hodgkin’s Lymphoma.
4 Nov, 2022 | 13:30h | UTCBrentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)
2022 ETA Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.
27 Oct, 2022 | 12:33h | UTCCommentary: New EU Guidelines: Individualize Care for Thyroid Cancer in Kids – Medscape (free registration required)
Systematic Review | Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
21 Oct, 2022 | 12:47h | UTC
Guideline | Diagnosis and management of febrile neutropenia in patients with cancer.
18 Oct, 2022 | 12:52h | UTCRelated:
Consensus recommendations for screening and managing childhood cancer survivors at risk for cardiomyopathy.
11 Oct, 2022 | 13:35h | UTCRelated:
Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia
Retrospective cohort | Outcomes in relapsed neuroblastoma treated with Irinotecan / Temozolomide / Dinutuximab / GM-CSF.
11 Oct, 2022 | 13:30h | UTC
RCT | Effect of the family-centered advance care planning for teens with cancer intervention on sustainability of congruence about end-of-life treatment preferences.
22 Sep, 2022 | 13:02h | UTCNews Release: Advance care planning for adolescents with cancer – University of Minnesota
Commentary: Study Examines Effects of Advance Care Planning for Adolescents With Cancer – The ASCO Post
Commentary on Twitter
Results of this trial showed that, for those who received the FACE®-TC intervention, the families’ knowledge of their adolescents’ end-of-life treatment preferences was sustained for 1 year, suggesting yearly follow-up sessions. @ChildrensNatl #EOL https://t.co/dngUhFQ5vQ
— JAMA Network Open (@JAMANetworkOpen) July 12, 2022
Large study unravels the risk factors for heart failure among childhood cancer survivors.
11 Sep, 2022 | 22:22h | UTC
Cohort Study | Children conceived via assisted reproductive technologies are at increased risk of childhood cancers.
7 Sep, 2022 | 12:32h | UTCAssisted Reproductive Technology and Risk of Childhood Cancers – JAMA Network Open
Invited Commentary: Fertility Treatment and Childhood Cancer Risk – JAMA Network Open
Commentary on Twitter
Children born of assisted reproductive technology (ART) conception was associated with an increased risk of overall childhood cancers compared with those conceived naturally and those with subfertility and non-ART conception. #OpenAccess #Research https://t.co/HylUVE4gFg
— JAMA Network Open (@JAMANetworkOpen) August 31, 2022
Systematic Review | Adverse drug reactions in pediatric onco-hematology
2 Sep, 2022 | 13:05h | UTCAdverse Drug Reactions in Pediatric Oncohematology: A Systematic Review – Frontiers in Pharmacology
Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
2 Sep, 2022 | 13:02h | UTC
Measuring quality of dying, death and end-of-life care for children and young people: a scoping review of available tools.
26 Aug, 2022 | 13:14h | UTC
M-A | Extent of tumor resection and survival in pediatric patients with high-grade gliomas.
17 Aug, 2022 | 14:00h | UTC
Commentary on Twitter
In this systematic review and meta-analysis of pediatric high-grade gliomas, gross total resection was associated with better overall survival than subtotal resection and biopsy. https://t.co/QpKiDKpYYs
— JAMA Network Open (@JAMANetworkOpen) August 16, 2022
Guideline | Pediatric differentiated thyroid carcinoma.
29 Jul, 2022 | 12:31h | UTC
Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children.
8 Jul, 2022 | 11:20h | UTC
Commentaries on Twitter
A multigene classifier reveals that malignant pediatric thyroid nodules have a unique molecular landscape vs those in adults. The classifier had a sensitivity of 96% & specificity of 78% for cancer detection & might reduce the need for diagnostic surgery: https://t.co/hdsPjGe9IR
— NatureRevClinOncol (@NatRevClinOncol) June 16, 2022
Pediatric thyroid cancer is on the rise. Its genomic landscape is unique; but, this retrospective case series shows that it may still be amenable to molecular classification—potentially decreasing diagnostic surgery & opening avenues for targeted therapy. https://t.co/KiYMsB1qGM
— JAMA Oncology (@JAMAOnc) June 10, 2022
Phase 1 single-arm study | Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma.
4 Jul, 2022 | 12:08h | UTCOncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Oncolytic Virus Infusion Promising as Brain-Stem Glioma Treatment — Phase I trial shows encouraging OS in children with diffuse intrinsic pontine glioma – MedPage Today (free registration required)
10-year outcomes of a RCT: Time to cure for childhood and young adult Acute Lymphoblastic Leukemia is independent of early risk factors.
20 Jun, 2022 | 00:49h | UTCTime to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)
RCT: Efficacy of mobile instant messaging–delivered brief motivational interviewing for parents to promote physical activity in pediatric cancer survivors.
15 Jun, 2022 | 10:53h | UTCInvited commentary: Improving Physical Activity in Pediatric Cancer Survivors—Engaging Parents – JAMA Network Open
Commentary on Twitter
This RCT found instant message-delivered brief motivational interviewing for parents increased physical activity, reduced cancer-related fatigue & improved QOL in children who survived cancer. @AnkieTCheung @WilliamHCLi @longkwanho @MichaelLam0705 https://t.co/K3N54iw0Qd
— JAMA Network Open (@JAMANetworkOpen) June 14, 2022
Cross Sectional Study: Underdiagnosis and undertreatment of modifiable cardiovascular risk factors among survivors of childhood cancer.
15 Jun, 2022 | 10:43h | UTCCommentaries:
Survivors of Childhood Cancer More Likely to Be Undertreated for CVD Risk Factors – AMJC
ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children.
7 Jun, 2022 | 10:52h | UTC